GSA Capital Partners’s DICE Therapeutics, Inc. Common Stock DICE Stock Holding History

GSA Capital Partners’s Portfolio DICE Stock Details DICE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2023 Q3	–	Sell	-6,402	Closed	-$297K	–	2050
2023 Q2	$297K	Buy	+6,402	New	+$221K	0.03%	1059
2023 Q1	–	Sell	-12,637	Closed	-$394K	–	2045
2022 Q4	$394K	Buy	+12,637	New	+$412K	0.05%	753
2022 Q3	–	Sell	-13,325	Closed	-$207K	–	1978
2022 Q2	$207K	Buy	+13,325	New	+$229K	0.03%	1056

GSA Capital Partners's DICE Position: Q3 2023 in Review

GSA Capital Partners sold out of DICE Therapeutics, Inc. Common Stock (DICE) in Q3 2023, closing a stake of 6,402 shares — an estimated $297K sold.

GSA Capital Partners first reported a position in DICE in Q2 2022 and held it in 3 quarters. The position peaked at $394K in Q4 2022. 0 funds tracked by Wall St. Rank hold DICE as of Q3 2023.

GSA Capital Partners reported no remaining DICE Therapeutics, Inc. Common Stock position as of Q3 2023 after selling out during the quarter.
GSA Capital Partners sold 6,402 DICE Therapeutics, Inc. Common Stock shares in Q3 2023, an estimated $297K.
GSA Capital Partners first reported a position in DICE Therapeutics, Inc. Common Stock in Q2 2022 and held it in 3 quarters.
GSA Capital Partners's DICE Therapeutics, Inc. Common Stock position peaked at $394K in Q4 2022.
0 funds tracked by Wall St. Rank held DICE Therapeutics, Inc. Common Stock as of Q3 2023.

Based on GSA Capital Partners's 13F filing for Q3 2023, filed 15 Nov 2023.